page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Butorphanol (Stadol)

Category:

  • Analgesic

Description:

  • Partial opiate agonist analgesic

Indications:

  • Moderate to severe pain (surgical, cancer, burns)

  • Migraine headache (nasal inhaler)

Contraindications:

  • Patients with impaired respiratory function.

Precautions:

  • Pregnancy Category C 

  • Patients will experience CNS effects of drowsiness and dizziness, therefore use caution with motor vehicle operation or other hazardous tasks.

  • Low physical dependence, however use in caution with unstable or history of abuse patients.

  • Avoid prolonged, sustained usage to decrease addiction potential.

  • Geriatric patients may have decreased medication clearance and elimination, therefore dosage must be modified.

  • Use with caution with other CNS depressive medications.

Adverse Reactions (Side Effects):

  • Sedation (43%)

  • Dizziness (19%)

  • Nausea and vomiting (13%)

Dosage:

Administered by injection (IM or IV) or nasal inhalation, adjusted to severity of pain

Adult:

  • Initial dose: 2mg IM or 1mg IV, repeated q3-4h as needed

  • Maintenance: 1-4mg IM or 0.5-2mg IV q3-4h

  • Inhalation: 1 spray (1mg per spray) in each nostril, if pain control not achieved then repeat with one spray in one nostril in 60-90 minutes, then q3-4h if needed

Geriatric or Impaired Hepatic or Renal Function:

  • One-half ( ½ ) normal dose IM or IV

  • Inhalation: 1 spray (1mg per spray) in each nostril, if pain control not achieved then repeat with one spray in one nostril in 90-120 minutes, then q6h if needed

 

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

Military Obstetrics & Gynecology
© 2003, 2004, 2005, 2006 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 


This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site